Overall rank by patents
#49,360
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
Omnia holds 5 US patents across 2 technology areas, rank #49,360 of 50,000 tracked assignees.
Omnia Medical, Llc has been granted 5 US utility patents between 2020 and 2023, placing Omnia Medical, Llc at rank #49,360 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.4 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a US Corporation, Omnia Medical, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Omnia sits between Ombraz, Inc. (5 patents, rank #49,356) and Omnisci, Inc. (5 patents, rank #49,364) - the closest US assignees by grant volume. The composite Innovation Score of 23.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Omnia Medical, Llc's 13.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Omnia Medical, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ombraz, Inc.
5 patents
Omcare Inc.
5 patents
Omni Powertrain Technologies, LLC
5 patents
OmniGuide, Inc.
5 patents
Omniox, Inc.
5 patents
Omniphysical LLC
5 patents
Omnis Mineral Technologies, LLC
5 patents
Omnisci, Inc.
5 patents
Omnia Medical, LLC
5 patents
What this shows Omnia holds 5 patents at rank #49,360, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,360 in granted patent volume.
Other assignees with the most granted patents in Omnia's primary technology class.
Omnia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
24 Top 87% higher than 13% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 40.0% |
| 2021 | 1 | 20.0% |
| 2023 | 2 | 40.0% |
Top 2 of 2 technology areas
Overall rank by patents
#49,360
Across all tracked assignees
23.7 out of 100
How to use this portfolio
Omnia's 5 grants land it in the top 87% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.